Abstract
The pathogenesis of rheumatoid arthritis (RA) is not known, but an abnormality in immunoregulation is thought to play a role. Some of the immunological abnormalities associated with other autoimmune diseases have been reported to be normalized in vitro by exposure of peripheral blood lymphocytes (PBL) to thymosin fraction 5 (TF5) (Horowitz et al., 1977 Scheinberg et al., 1979; Lavastida et al., 1981; Goldstein et al., 1976), thus providing a rationale for the use of this immunomodulating agent in these disorders. The studies being presented today were undertaken to evaluate the effect of TF5 on in vitro immunoregulatory function in patients with RA and establish the relevance of clinical application of thymosin in the treatment of this common disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdou, N. I., Lindsley, H. B., Racela, L. S., Pascual, E., and Hassanein, K. M., 1981, Suppressor T-cell dysfunction and antisuppressor cell antibody in active early rheumatoid arthritis, J. Rheum. 8:9.
Burmester, G. R., Yu, D. T. Y., Irani, A. M., Kunkel, H. G., and Winchester, R. J., 1981, 1a + T-cells in synovial fluid and tissues of patients with rheumatoid arthritis, Arthritis Rheum.24:1370.
Chattopadhyay, C., Chattopadhyay, H., Natvig, J. B., and Melbye, O. J., 1979, Rheumatoid synovial lymphocytes lack concanavalin-A-activated suppressor cell activity, Scand. J. Immunol. 10:479.
Doubloug, J. H., Chattopadhyay, C., Forre, O., Hoyeraal, H. M., and Natvig, J. B., 1981, Con A-induced suppressor cell activity and T-lymphocyte of patients with rheumatoid arthritis and juvenile rheumatoid arthritis, Scand. J. Immunol. 13:367.
Espinoza, L. R., Gaylord, S. W., Bergen, L., Vasey, F. B., Germain, B. F., and Osterland, C. K., 1980, The “active” rosette test in rheumatoid arthritis: Correlation with disease activity, Clin.Immunol. Immunopathol. 17:110.
Fineman, S. M., Mudawwar, F. B., and Geha, R. S., 1979, Characteristics and mechanisms of action of the concanavalin-A activated suppressor cell in man, Cell. Immunol. 45:120.
Goldstein, A. L., Thurman, G. B., Cohen, G. H., and Rossio, H., 1976, The endocrine thymus: Role for thymosin in the treatment of autoimmune disease, Ann. N.Y. Acad. Sci. 274:390.
Horowitz, S., Borcherding, W., Moorthy, A. V., Chesney, R., Schulte-Wisserman, H., Hong, R., and Goldstein, A. L., 1977, Induction of suppressor T-cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium, Science 197:999.
Janossy, G., Panayi, G., Duke, O., Bofill, M, Poulter, L. W., and Goldstein, G., 1981, Rheumatoid arthritis: A disease of T-lymphocyte/macrophage immunoregulation, Lancet 2:839.
Keystone, E. C., Gladman, D. C., Buchanan, R., Cane, D., and Poplonski, L., 1980, Impaired antigen-specific suppressor cell activity in patients with rheumatoid arthritis, Arthritis Rheum.23:1246.
Lavastida, M. I., Goldstein, A. L., and Daniels, J. C., 1981, Thymus administration in autoimmune disorders, Thymus 2:287.
Moutsopoulos, H., Fye, K. H., Sawada, S., Becker, M. J., Goldstein, A., and Talal, N., 1976, Invitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases, Clin. Exp.Immunol. 26:573.
Reinherz, E. L., and Schlossman, S. F., 1980, Regulation of the immune response-inducer and suppressor T-lymphocyte subsets in human beings, N. Engl. J. Med. 303:370.
Ropes, M. W., Bennett, G. A., Cobb, S., Macox, R., and Jessar, R. A., 1958, Diagnostic criteria for rheumatoid arthritis, Bull. Rheum. Dis. 9:175.
Scheinberg, M. A., Cathcart, E. S., and Goldstein, A. L., 1979, Thymosin induced reduction of null cells in peripheral blood lymphocytes of patients with systemic lupus erythematosus, Lancet 1:424.
Shou, L., Schwartz, S. A., and Good, R. A., 1976, Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors, J. Exp. Med. 143:1100.
Tosato, G., Steinberg, A. D., and Blaese, R. M., 1981, Defective EBV-specific suppressor T-cell function in rheumatoid arthritis, N. Engl. J. Med. 305:1238.
Veys, E. M., Hermanns, P. L., Goldstein, G., Kung, P., Schindler, J., and Van Wauwe, J., 1981, T-cell subpopulations determined by monoclonal antibodies in RA—Influence of immunomodulating agents, Adv. Inflammation Res. 3:155.
Waldmann, T. A., Blaese, R. M., Broder, S., and Krakauer, R. S., 1978, Disorders of suppressor immunoregulatory cells in the pathogenesis of immunodeficiency and autoimmunity, Ann. Intern.Med. 88:225.
Zilko, P. J., Dawkins, R. L., and Carrano, J. A., 1980, Nonspecific suppression and genetic factors in autoimmunity, in: Immunoregulation and Autoimmunity (R. W. Krakauer and M. K. Cathcart, eds.), pp. 173–181, Elsevier/North-Holland, Amsterdam.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Jacobs, R.P., Richardson, C.S.E., Riley, S.B., Zatz, M., Hatcher, J., Goldstein, A.L. (1984). Effect of Thymosin on in Vitro Immune Function in Patients with Rheumatoid Arthritis. In: Goldstein, A.L. (eds) Thymic Hormones and Lymphokines. GWUMC Department of Biochemistry Annual Spring Symposia. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4745-3_58
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4745-3_58
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4747-7
Online ISBN: 978-1-4684-4745-3
eBook Packages: Springer Book Archive